MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

DexCom Company Profile (NASDAQ:DXCM)

Consensus Ratings for DexCom (NASDAQ:DXCM) (?)
Ratings Breakdown: 2 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $94.91 (69.12% upside)

Current Analysts' Coverage Summary for DexCom (NASDAQ:DXCM)
Show:
DateFirmActionRatingPrice TargetActions
2/9/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2016Robert W. BairdDowngradeOutperform -> Neutral$100.00 -> $74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Morgan StanleyInitiated CoverageOverweight$106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015Sterne Agee CRTUpgradeNeutral -> Buy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015Leerink SwannUpgradeMarket Perform -> Outperform$90.00 -> $100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2015JPMorgan Chase & Co.Boost Price TargetOverweight$95.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Jefferies GroupBoost Price TargetBuy$80.00 -> $98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/18/2015Cowen and CompanyBoost Price Target$80.00 -> $100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015OppenheimerBoost Price TargetMarket Perform$64.00 -> $69.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015WedbushBoost Price TargetBuy$73.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2014Benchmark Co.Set Price TargetBuy$57.00 -> $69.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Northcoast ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2014Raymond JamesReiterated RatingOutperform$44.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014Feltl & Co.DowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha